Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
08/10/2026 14:04
BRIEF-Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances Oct 8 (Reuters) - Pacira BioSciences, Inc. PCRX.O:
VIATRIS - PACIRA TO PAY VIATRIS $62 MILLION TERMINATION FEE UNDER SPECIFIED CIRCUMSTANCES - SEC FILING
Source text: [ID:n0001140361-26-039024]
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viatris
See all newsBrief: Viatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Deals of the day-Mergers and acquisitions
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal